No Data
By-Health Co., Ltd. (300146.SZ): has established traditional medicine store and pharmacy channels in several countries in Southeast Asia, as well as cross-border and local e-commerce channels. Currently, the scale is still relatively small.
Grace Bond on November 7th | By-Health Co., Ltd. (300146.SZ) accepted a specific survey on November 6, 2024, on the "company's overseas business layout". The company stated that the current overseas layout is mainly based on the lifespace brand, and has set up traditional pharmacies and beauty channels in several countries in Southeast Asia, as well as cross-border and local e-commerce channels, with the current scale still relatively small.
By-Health Co., Ltd. (300146.SZ): Currently, the inventory levels of the two major core product channels have been controlled within a reasonable range.
Gelonghui November 7th | By-Health Co., Ltd. (300146.SZ) accepted specific object research on November 6, 2024, regarding the progress of the switch of the two core products and the inventory situation of the channels. The company stated that the switch between old and new products had a significant impact on the company's performance in the third quarter, and it is expected to be completed within the year. Currently, the inventory levels of the two core products in the channels have been controlled within a reasonable range.
Major MSCI adjustment! Brokerage stocks are most favored, 20 companies are being removed.
Due to the expectations of potential bullish policies, capital is pouring into the cryptocurrency market. CoinShares Ltd. data shows that Bitcoin investment products received $1.27 billion USD (approximately RMB 9.2 billion) in inflows last week as the price of Bitcoin soared to its highest level in over a month.
Byhealth's (SZSE:300146) Anemic Earnings Might Be Worse Than You Think
By-Health Co., Ltd. (300146.SZ): This buyback has not yet been implemented.
Gelonghui November 1st | By-Health Co., Ltd. (300146.SZ) announced that, as of October 31, 2024, the company has not yet implemented this repurchase.
Facing challenges with performance under pressure in the first three quarters, by-health co., ltd. actively responded with proactive transformation.
Guangzhou, October 29, 2024 / PRNewswire / -- Since the beginning of this year, the consumer environment in the VDS industry has been continuously changing. Influenced by multiple factors such as intensified market competition and corporate operational adjustments, the leading company, by-health co., ltd. (300146.SZ), has been under performance pressure. In the first three quarters of this year, by-health co., ltd. achieved revenue of 5.734 billion yuan, with a net income attributable to the parent company of 0.869 billion yuan, both decreasing compared to the same period last year. In terms of offline channels, according to CMH data from Zhongkang, from January to August this year, the VDS sales in national retail pharmacies dropped by 20% year-on-year, which significantly impacted by-health co., ltd. As for online channels
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target PriceNo Data
No Data
